The minimum follow-up was 6 months
Week 1-2 Improved sleep quality, increased energy, possible water retention and joint stiffness Week 2-4 Enhanced exercise recovery, skin improvement, possible carpal tunnel symptoms Month 1-2 Noticeable fat loss (especially abdominal), improved skin elasticity and texture Month 2-3 Continued fat loss, lean mass improvements, hair/nail growth, reduced recovery time Month 3-6 Significant body composition changes, improved bone density, sustained energy/well-being Week 0-0 Maintained benefits
The role of GLP-1R in AD is reflected mainly in the following aspects: it can decrease A deposition and inhibit tau protein hyperphosphorylation, reduce neuroinflammation and oxidative stress (OS) ( 2.1 GLP-1R and A deposition A is a protein fragment produced by the cleavage of amyloid precursor protein (APP) by a series of enzymes and is one of the key factors in AD research (Sambamurti et al., 2002
Can my genetic makeup affect how semaglutide storage matters